Author (Corporate) | European Commission: Press and Communication Service |
---|---|
Series Title | Press Release |
Series Details | IP/05/1428 (16.11.05) |
Publication Date | 16/11/2005 |
Content Type | News |
The European Commission on 16 November 2005 proposed new EU wide rules to facilitate gene, cell and tissue-based therapies. These so-called advanced therapies enable revolutionary treatment of a number of diseases or injuries, such as cancer, Parkinson’s disease, skin in burn victims or serious cartilage damage. The Commission proposed a centralised marketing authorisation procedure, a new expert Committee, strengthened requirements for risk management and traceability and top-quality scientific advice. Ethical decisions about the use or non-use of germ cells or embryonic stem cells were to remain under the full responsibility of individual Member States. |
|
Source Link | http://europa.eu/rapid/pressReleasesAction.do?reference=IP/05/1428&format=HTML&aged=0&language=EN&guiLanguage=en |
Related Links |
|
Subject Categories | Business and Industry, Culture, Education and Research, Values and Beliefs |
Countries / Regions | Europe |